Literature DB >> 17785544

Inhibitor-kappaB kinase in tumor promotion and suppression during progression of squamous cell carcinoma.

Carter Van Waes1, Ming Yu, Liesl Nottingham, Michael Karin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17785544     DOI： 10.1158/1078-0432.CCR-07-1287

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  16 in total

Review 1.  IκB kinase alpha and cancer.

Authors:  Shuang Liu; Zhisong Chen; Feng Zhu; Yinling Hu
Journal:  J Interferon Cytokine Res       Date:  2011-12-07       Impact factor: 2.607

Review 2.  NF-κB addiction and its role in cancer: 'one size does not fit all'.

Authors:  M M Chaturvedi; B Sung; V R Yadav; R Kannappan; B B Aggarwal
Journal:  Oncogene       Date:  2010-12-20       Impact factor: 9.867

3.  IKKα represses a network of inflammation and proliferation pathways and elevates c-Myc antagonists and differentiation in a dose-dependent manner in the skin.

Authors:  B Liu; J Willette-Brown; S Liu; X Chen; S M Fischer; Y Hu
Journal:  Cell Death Differ       Date:  2011-05-13       Impact factor: 15.828

4.  NF-kappaB protects human papillomavirus type 38 E6/E7-immortalized human keratinocytes against tumor necrosis factor alpha and UV-mediated apoptosis.

Authors:  Ishraq Hussain; Ikbal Fathallah; Rosita Accardi; Jiping Yue; Djamel Saidj; Ruchi Shukla; Uzma Hasan; Tarik Gheit; Yamei Niu; Massimo Tommasino; Bakary S Sylla
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

5.  Reduction of IKKalpha expression promotes chronic ultraviolet B exposure-induced skin inflammation and carcinogenesis.

Authors:  Xiaojun Xia; Eunmi Park; Bigang Liu; Jami Willette-Brown; Wanghua Gong; Jiming Wang; David Mitchell; Susan M Fischer; Yinling Hu
Journal:  Am J Pathol       Date:  2010-03-19       Impact factor: 4.307

6.  The tumor suppressor activity of IKKalpha in stratified epithelia is exerted in part via the TGF-beta antiproliferative pathway.

Authors:  Barbara Marinari; Francesca Moretti; Elisabetta Botti; Maria Laura Giustizieri; Pascal Descargues; Alessandro Giunta; Carmine Stolfi; Costanza Ballaro; Marina Papoutsaki; Stefano Alemà; Giovanni Monteleone; Sergio Chimenti; Michael Karin; Antonio Costanzo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-28       Impact factor: 11.205

7.  Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer.

Authors:  Rita Das; Jamie Coupar; Paul E Clavijo; Anthony Saleh; Tsu-Fan Cheng; Xinping Yang; Jianhong Chen; Carter Van Waes; Zhong Chen
Journal:  Mol Carcinog       Date:  2018-11-28       Impact factor: 4.784

Review 8.  Current and potential inflammation targeted therapies in head and neck cancer.

Authors:  Frederick Wang; Pattatheyil Arun; Jay Friedman; Zhong Chen; Carter Van Waes
Journal:  Curr Opin Pharmacol       Date:  2009-06-29       Impact factor: 5.547

Review 9.  Critical role of IkappaB kinase alpha in embryonic skin development and skin carcinogenesis.

Authors:  Feng Zhu; Eunmi Park; Bigang Liu; Xiaojun Xia; Susan M Fischer; Yinling Hu
Journal:  Histol Histopathol       Date:  2009-02       Impact factor: 2.303

Review 10.  Hypoxia. Regulation of NFkappaB signalling during inflammation: the role of hydroxylases.

Authors:  Kathryn M Oliver; Cormac T Taylor; Eoin P Cummins
Journal:  Arthritis Res Ther       Date:  2009-02-23       Impact factor: 5.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.